Lipid nanoparticles deliver mRNA to the blood–brain barrier-Reference-Cited by-同舟云学术

Lipid nanoparticles deliver mRNA to the blood–brain barrier

Published:2024-08-01 Issue: Volume: Page:
ISSN:1998-0124
Container-title:Nano Research
language:en
Short-container-title:Nano Res.

Author:

Kuzminich Yanina,Shakked Avraham,Calkins Randi,Rudden Sebastian,Jones Camille,Doan Jessie,Jang Bora,Echeverri Elisa Schrader,Zenhausern Ryan,Lian Liming,Loughrey David,Peck Hannah E.,Wiese Rachelle,Koveal Dorothy,Santangelo Philip J.,Dahlman James E.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12274-024-6827-7.pdf

Reference40 articles.

1. Baden, L. R.; El Sahly, H. M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S. A.; Rouphael, N.; Creech, C. B. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021, 384, 403–416.

2. Polack, F. P.; Thomas, S. J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J. L.; Marc, G. P.; Moreira, E. D.; Zerbini, C. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 2020, 383, 2603–2615.

3. Adams, D.; Gonzalez-Duarte, A.; O’Riordan, W. D.; Yang, C. C.; Ueda, M.; Kristen, A. V.; Tournev, I.; Schmidt, H. H.; Coelho, T.; Berk, J. L. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 2018, 379, 11–21.

4. Gillmore, J. D.; Gane, E.; Taubel, J.; Kao, J.; Fontana, M.; Maitland, M. L.; Seitzer, J.; O’Connell, D.; Walsh, K. R.; Wood, K. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 2021, 385, 493–502.

5. Longhurst, H. J.; Lindsay, K.; Petersen, R. S.; Fijen, L. M.; Gurugama, P.; Maag, D.; Butler, J. S.; Shah, M. Y.; Golden, A.; Xu, Y. X. et al. CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N. Engl. J. Med. 2024, 390, 432–441.